Trial Profile
Phase I/II clinical pilot study of Hycamtin in combination with Cisplatin for extensive-disease small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Topotecan (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nippon Kayaku
- 27 May 2016 New trial record